Dyne Therapeutics, Inc. Common Stock

Go to Dyne Therapeutics, Inc. Common Stock Website

$10.25

0.00 (0.00%)
Live
Previous Close

$10.25

Day Range

$0 - $0

Previous Day Range

$10.1 - $10.45

Market Cap

$1.4 billion USD

Day Vol.

0

Previous Day Vol.

1.9 million

Currency

USD

Primary Exchange

Nasdaq

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therape...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Dyne Therapeutics announced a delay in FDA approval for DYNE-101, an experimental therapy for myotonic dystrophy type 1, pushing back enrollment and potential submission timelines. The stock price dropped 21.42% following the announcement.

Related tickers: DYN.

Read Full Article

Dyne Therapeutics plans to raise $200 million through a public offering of 24,242,425 common stock shares at $8.25 per share, with potential additional shares through underwriter option.

Related tickers: DYN, MS, MSpA, MSpE, MSpF, MSpI, MSpK, MSpL, MSpO, MSpP, MSpQ, JEF.

Read Full Article
Trending Tickers

Please sign in to view